American International Group, Inc. Exelixis, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $379,478 - $450,219	-18,814 Reduced 4.46%	403,286 $9.57 Million
Q4 2023 Feb 13, 2024	SELL	$19.25 - $24.13 $550,607 - $690,190	-28,603 Reduced 6.35%	422,100 $10.1 Million
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $813,160 - $971,179	-42,708 Reduced 8.66%	450,703 $9.85 Million
Q2 2023 Aug 04, 2023	SELL	$18.17 - $20.48 $144,287 - $162,631	-7,941 Reduced 1.58%	493,411 $9.43 Million
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $37,897 - $45,128	-2,325 Reduced 0.46%	501,352 $9.73 Million
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $83,013 - $96,497	-5,549 Reduced 1.09%	503,677 $8.08 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $345,885 - $491,253	-22,059 Reduced 4.15%	509,226 $7.99 Million
Q2 2022 Aug 12, 2022	SELL	$17.44 - $23.16 $120,179 - $159,595	-6,891 Reduced 1.28%	531,285 $11.1 Million
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $17,030 - $22,670	1,000 Added 0.19%	538,176 $12.2 Million
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $120,399 - $166,309	-7,601 Reduced 1.4%	537,176 $9.82 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $231,134 - $299,765	-14,180 Reduced 2.54%	544,777 $11.5 Million
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $135,612 - $193,105	-7,555 Reduced 1.33%	558,957 $10.2 Million
Q1 2021 May 07, 2021	BUY	$20.53 - $25.22 $110,512 - $135,759	5,383 Added 0.96%	566,512 $12.8 Million
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $121,668 - $164,076	-6,616 Reduced 1.17%	561,129 $11.3 Million
Q3 2020 Nov 04, 2020	SELL	$20.67 - $26.94 $139,543 - $181,871	-6,751 Reduced 1.18%	567,745 $13.9 Million
Q2 2020 Aug 12, 2020	SELL	$16.46 - $27.42 $308,427 - $513,795	-18,738 Reduced 3.16%	574,496 $13.6 Million
Q1 2020 May 04, 2020	BUY	$14.46 - $21.8 $86,311 - $130,124	5,969 Added 1.02%	593,234 $10.2 Million
Q4 2019 Feb 05, 2020	BUY	$15.15 - $18.89 $79,567 - $99,210	5,252 Added 0.9%	587,265 $10.3 Million
Q3 2019 Nov 08, 2019	SELL	$17.68 - $22.65 $150,722 - $193,091	-8,525 Reduced 1.44%	582,013 $10.3 Million
Q2 2019 Aug 13, 2019	SELL	$18.93 - $24.75 $183,412 - $239,802	-9,689 Reduced 1.61%	590,538 $12.6 Million
Q1 2019 May 06, 2019	SELL	$19.6 - $24.76 $212,816 - $268,844	-10,858 Reduced 1.78%	600,227 $14.3 Million
Q4 2018 Feb 13, 2019	BUY	$13.65 - $21.8 $48,484 - $77,433	3,552 Added 0.58%	611,085 $12 Million
Q3 2018 Nov 09, 2018	BUY	$15.87 - $22.4 $9.53 Million - $13.4 Million	600,441 Added 8466.46%	607,533 $10.8 Million
Q2 2018 Aug 08, 2018	BUY	$18.56 - $22.45 $7,887 - $9,541	425 Added 6.37%	7,092 $153,000
Q1 2018 May 07, 2018	SELL	$22.15 - $31.89 $3,920 - $5,644	-177 Reduced 2.59%	6,667 $148,000
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $165,830 - $211,684	6,844	6,844 $208,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account